Literature DB >> 6989150

Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa.

R Rappaport, C Prevot, P Czernichow.   

Abstract

Anorexia nervosa in childhood and adolescence, associated with impaired growth can be considered as a form of chronic malnutrition. Twelve patients aged 11 to 17 years were investigated. In spite of increased GH secretion, plasma somatomedin activities were diminished in 8 cases. Plasma T4, T3 and arginine stimulated insulin secretion were also decreased. In six patients who gained weight a significant negative correlation was found between weight deficit and plasma somatomedin activity. Prolonged administration of growth hormone in one case did not stimulate the generation of somatomedin activity. Nutrition and increased insulin secretion could plan a role in changes observed during recovery.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6989150     DOI: 10.1111/j.1651-2227.1980.tb07026.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  4 in total

1.  Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

Authors:  A G Thomas; J M Holly; F Taylor; V Miller
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

2.  Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.

Authors:  A Masuda; T Shibasaki; M Hotta; H Suematsu; K Shizume
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

3.  "Negative growth" in anorexia nervosa assessed by knemometry.

Authors:  M Hermanussen; K Geiger-Benoit; W G Sippell
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

Review 4.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.